This modification maintains the nuclear NAD salvage pathway and supports tumor cell survival under glucose deprivation, suggesting that NMNAT1 and its associated metabolic circuitry may also represent attractive targets within the lactylation network of pancreatic cancer (124). The gene discussed is NMNAT1; the disease is neoplasm.